Poster is available to registered attendees only via the ASH annual meeting virtual platform, as per congress regulations.

Session Date: December 8, 2025
Session Time: 6:00 PM - 8:00 PM
Presentation Time: 6:00 PM - 8:00 PM
Room: OCCC - West Halls B3-B4

Study funded by Sanofi.

Link to online abstract

Publication
  • ASH •
  • 8 December, 2025 •
  • •

Emapalumab induces rapid, durable responses and reliable bridging to curative HSCT in patients with primary HLH: Pooled analysis of prospective trials NI-0501-04, NI-0501-05 and NI-0501-09

Michael B. Jordan, Franco Locatelli, Didier Halimi, Elena Burillo, Brian D. Jamieson, Andrew Danquah, Emmanuel Monnet

Publication
  • ASH •
  • 8 December, 2025 •
  • •

Treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib following a switch from ruxolitinib: The MY-PAC Study

Douglas Tremblay, Abiola Oladapo, Michael Marrone, Puja Aggarwal, Caleb Paydar, Djibril Liassou, Purvi Suthar, Adina Geprifti, Michael Vredenburg , Bruce Feinberg, James Rossetti, Naveen Pemmaraju

Publication
  • ASH •
  • 8 December, 2025 •
  • •

Incidence, prevalence, and clinical outcomes of myelofibrosis with and without cytopenia in the United States

Aaron T Gerds, Lindsay AM Rein, Nicole M Engel-Nitz, Michael Marrone, Jeffrey McPheeters, Abiola Oladapo, Purvi Suthar, Michael Vredenburg , Yong Zhu, Lucia Masarova

Publication
  • EHA •
  • 12 June, 2025 •
  • •

Emapalumab in patients with primary hemophagocytic lymphohistiocytosis: Efficacy and safety outcomes from a multinational, open-label, single-arm study

Franco Locatelli, Ahmed Naqvi, Beki James, Julián Sevilla, Simone Cesaro, Stephan Ehl, Didier Halimi, Emmanuel Monnet, Ben Peace, Veronica Asnaghi, Cristina de Min, Michael Jordan

Available materials

Poster
Sign up for alerts